FORREST YORGASON: Open Payments
NPI 1932823572 · SPRINGVILLE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,142 in 74 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $154 · 2025 $1,142
Food & beverage: $1,142
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $177 |
| ABBVIE INC. | 15 | $173 |
| Neurocrine BioSciences, Inc. | 7 | $154 |
| Teva Pharmaceuticals USA, Inc. | 16 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $90 |
| Lundbeck LLC | 5 | $90 |
| Biogen, Inc. | 4 | $81 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| Tris Pharma Inc | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
Products named: TRINTELLIX, VRAYLAR, INGREZZA, REXULTI, AUSTEDO XR, CAPLYTA, ZURZUVAE, INVEGA SUSTENNA.
Industry payments across UT — which companies pay providers there.
